Keio Innovation Initiative is a venture capital firm established by Keio University in Tokyo, Japan. It aims to advance society by investing in startups that leverage Keio’s research outcomes to create new industries and improve the efficiency of research and development investment. The firm focuses on backing companies in digital health, healthcare technology, software, artificial intelligence and machine learning, the Internet of Things, robotics and drones, and related technologies, helping translate university research into commercial ventures. By supporting entrepreneurship and innovative technologies, Keio Innovation Initiative seeks to contribute to Japan’s growth and create opportunities for transformative innovations.
JiMED develops a wireless embedded Brain-Computer Interface (BCI) system designed to read brain activity. The company offers an implantable device that uses artificial intelligence to interpret brain signals, enabling individuals with conditions like ALS to enhance communication and improve quality of life.
LIFESCAPES
Seed Round in 2022
LIFESCAPES is a research and manufacturing company specializing in brain-computer interface equipment, particularly for neurorehabilitation. The company's technology focuses on aiding stroke patients by enhancing brain plasticity, which allows individuals to overcome limitations and improve their quality of life. LIFESCAPES' devices are designed to extract and analyze brain-wave data in real-time, monitoring the activity of the functional compensation circuits in stroke patients. This innovative approach enables healthcare professionals to assist patients in regaining movement and addressing movement disorders, ultimately facilitating a more normal and fulfilling life for those affected.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.